Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection

Gastric cancer: New genetic developments

Henry T. Lynch, William M. Grady, Gianpaolo Suriano et al. · Journal of Surgical Oncology · 2005 · 218 citations

A mechanism for epithelial–mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3)

Christer Högstrand, Peter Kille, M. Leigh Ackland et al. · Biochemical Journal · 2013 · 141 citations · Full text

SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

Django Sussman, Leia M. Smith, Martha E. Anderson et al. · Molecular Cancer Therapeutics · 2014 · 128 citations

Metastatic Breast Cancer, Breast Oncology, Drug Targeting +11

LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling

Hui-Wen Lue, Xiaojian Yang, Ruoxiang Wang et al. · PLoS ONE · 2011 · 115 citations · Full text

Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma

Chen Wu, Dong Li, Wei‐Hua Jia et al. · Nature Genetics · 2013 · 107 citations

Somatic Variant, Esophageal Cancer, Medicine +7